Corpus 1,276 assessed · 1,177 scored · 644 reproduced ≥75 · 170 flagged ·∅ 74/100

Publications 2 Datasets 392.5k Experiments 4.7k

Explore

Filters: South China University of Technology ✕ 1 ✕ clear all

2 matching publication(s)

Publication	Journal	Year	Score	Verdict
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104). PMID 38897205	Cell Rep Med	2024	72	L1 72/100
Improving recombinant protein production by yeast through genome-scale modeling using proteome constraints. PMID 35624178	Nat Commun	2022	84	L1 84/100

Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104).

PMID 38897205 · Cell Rep Med · 2024

L1 72/100

Improving recombinant protein production by yeast through genome-scale modeling using proteome constraints.

PMID 35624178 · Nat Commun · 2022

L1 84/100